Medifast (NYSE:MED) Stock Price Breaks Above 200-Day Moving Average – What’s Next?

24 Sep 2026, 23:21 by Sarita Garza · The Markets Daily

Shares of Medifast Inc (NYSE:MED – Get Free Report) crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $11.28 and traded as high as $12.48. Medifast shares last traded at $12.15, with a volume of 72,553 shares.

Analyst Ratings Changes

A number of analysts have weighed in on MED shares. Weiss Ratings upgraded Medifast from a “sell (e+)” rating to a “sell (d)” rating in a research note on Monday, August 17th. Zacks Research lowered shares of Medifast from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Two equities research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Medifast currently has an average rating of “Reduce” and a consensus target price of $12.00.

View Our Latest Stock Report on Medifast

Medifast Price Performance

The business has a 50-day moving average of $11.51 and a two-hundred day moving average of $11.29. The company has a market cap of $132.98 million, a P/E ratio of -5.10 and a beta of 0.71.

Medifast (NYSE:MED – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The specialty retailer reported ($0.28) earnings per share for the quarter, topping the consensus estimate of ($0.65) by $0.37. The business had revenue of $76.38 million during the quarter, compared to the consensus estimate of $72.70 million. Medifast had a negative return on equity of 6.69% and a negative net margin of 8.08%.Medifast has set its FY 2026 guidance at -1.750–0.250 EPS and its Q3 2026 guidance at -0.650–0.150 EPS. Equities analysts anticipate that Medifast Inc will post -1.04 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Parsa Kiai purchased 43,150 shares of the business’s stock in a transaction on Wednesday, August 26th. The shares were bought at an average cost of $12.26 per share, with a total value of $529,019.00. Following the transaction, the director owned 707,492 shares of the company’s stock, valued at approximately $8,673,851.92. This trade represents a 6.50% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have acquired 119,966 shares of company stock valued at $1,423,576 over the last 90 days. 3.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Medifast

Institutional investors have recently made changes to their positions in the company. State of Wyoming boosted its stake in shares of Medifast by 19.8% during the 1st quarter. State of Wyoming now owns 6,646 shares of the specialty retailer’s stock worth $68,000 after acquiring an additional 1,097 shares in the last quarter. Ancora Advisors LLC acquired a new position in Medifast in the 2nd quarter worth about $75,000. Ieq Capital LLC purchased a new position in Medifast during the second quarter worth approximately $114,000. Squarepoint Ops LLC purchased a new position in Medifast during the second quarter worth approximately $214,000. Finally, Chico Wealth RIA acquired a new stake in Medifast in the second quarter valued at approximately $223,000. 95.51% of the stock is owned by hedge funds and other institutional investors.

Medifast Company Profile

(Get Free Report)

Medifast, Inc (NYSE: MED) is a health and wellness company that provides weight-management and healthy-lifestyle products and programs. Its principal brand is OPTAVIA, which offers structured plans designed to support weight loss, nutrition, and long-term habit development.

The company’s product portfolio includes meal-replacement shakes, bars, snacks, entrees, beverages, supplements, and other packaged “Fuelings.” Medifast also supports customers through independent OPTAVIA Coaches, who provide guidance, accountability, and lifestyle support through the company’s direct-selling model.